Physician profile
Mary Lee
NPI 1831544642
$1,975.38
in general payments reported to CMS, 2019-2025
21 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $732 · 2021: $40.41 · 2022: $157 · 2023: $215 · 2024: $333 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $301.87 | 2019-2025 | |
| Novo Nordisk INC | $255.21 | 2020-2025 | Ozempic |
| Pfizer INC. | $186.74 | 2019-2025 | |
| Heartflow, INC. | $170.04 | 2020-2025 | |
| Cardiva Medical, INC. | $125.59 | 2020 | |
| Janssen Pharmaceuticals, INC | $125.29 | 2020-2022 | |
| Vifor Pharma, INC. | $106.06 | 2020 | |
| Medtronic, INC. | $100.82 | 2021-2022 | |
| Medline Industries LP | $89.20 | 2023 | |
| Amgen INC. | $87.09 | 2020-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $67.97 | 2022-2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $48.73 | 2020-2023 | Brilinta, Farxiga |
| Abbott Laboratories | $48.01 | 2022-2025 | Cardiomems |
| Inspire Medical Systems, INC. | $47.99 | 2025 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.42 | 2025 | Lifevest |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $36.91 | 2025 | Zepbound |
| Scpharmaceuticals INC. | $35.06 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $29.96 | 2022-2024 | Eliquis |
| Endotronix, INC. | $29.83 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Vital Connect, INC | $22.10 | 2024 | Vitalpatch Rtm |
| Alexion Pharmaceuticals, INC. | $21.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.